Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of non-small cell lung cancer (NSCLC). Most randomized clinical trials have excluded patients with brain metastasis (BM), and real-life patients with NSCLC who receive ICIs are not routinely scanned with magne...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjørnhart, Birgitte, Hansen, Karin Holmskov, Asmussen, Jon Thor, Jørgensen, Trine Lembrecht, Herrstedt, Jørn, Schytte, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997168/
https://www.ncbi.nlm.nih.gov/pubmed/35406453
http://dx.doi.org/10.3390/cancers14071682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997168/
https://www.ncbi.nlm.nih.gov/pubmed/35406453
http://dx.doi.org/10.3390/cancers14071682

Ejemplares similares